![Foto de Juan](/img/nophoto.png)
Juan
Ruiz Bañobre
Publicacións nas que colabora con Juan Ruiz Bañobre (12)
2023
-
Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial
ESMO Open, Vol. 8, Núm. 4
-
MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles
iScience, Vol. 26, Núm. 3
-
Noninvasive detection of microsatellite instability in patients with endometrial cancer
International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217
2022
-
Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy
Scientific Reports, Vol. 12, Núm. 1
-
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
Clinical Epigenetics, Vol. 14, Núm. 1
2021
-
Molecularly targeted therapy in metastatic CRC
Foundations of Colorectal Cancer (Elsevier), pp. 357-364
-
Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study
ESMO open, Vol. 6, Núm. 2, pp. 100090
2020
-
Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation
Carcinogenesis, Vol. 41, Núm. 11, pp. 1498-1506
2019
-
Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 142, pp. 449-459
2017
-
Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome
APMIS
-
Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature
Lung Cancer, Vol. 108, pp. 217-221